To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 38,565 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 5.79% of the total position.
      94Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 139,650 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 1.15% of the total position.
      52Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 47,655 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 1.5% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 79,774 shares, the number of shares held decreased 2.94% compared to the previous period and now represents 9.55% of the total position.
      20Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 88,665 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 1.86% of the total position.
      33Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 10,515 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 4.71% of the total position.
      24Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 17,790 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 1.61% of the total position.
      32Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 82,965 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 3.21% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 9,300 shares, the number of shares held decreased 1.75% compared to the previous period and now represents 2.35% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 1,170 shares, the number of shares held decreased 1.74% compared to the previous period and now represents 3.54% of the total position.
      1Comment
      Report
       
       
       
       

      Most Discussed